R
RCE
RECCE PHARMACEUTICAL
0.57
0.000.00%Closed07:00 02/09 AEDT
OPEN/PREV CLOSE--/0.590
TODAY RANGE-
VOL--
MARKET CAP164.83M
52 WEEK RANGE0.275-0.730
AVG VOL (3M)187.47K
% TURNOVER0.05%
TURNOVER--
P/E (TTM)-6.3053
% RANGE--
EPS(TTM)-0.0904
P/E(FORWARD)-7.7551
P/B-53.7736
BVPS-0.0106
DIVIDEND--
P/S21.35
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP94.05M
SHARES OUTSTANDING289.18M
NEXT EARNINGS02/26-03/02
FREE FLOAT164.99M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·01/30 02:02
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·01/13 23:39
AUD $5.3m R&D Rebate Received
ASX·01/05 00:00
corporate presentation
ASX·12/15/2025 22:51
RCE Awarded Advanced Overseas Finding up to A$85m
ASX·12/02/2025 00:00
corporate presentation
ASX·11/26/2025 23:07
Hong Kong Patent Granted for RECCE Anti-Infectives
ASX·11/25/2025 22:52
Positive Efficacy Data for Inhaled R327 in HAP/VAP Model
ASX·11/14/2025 05:10
Passing of Dr Graham Melrose - Recce founder and inventor
ASX·11/11/2025 00:00
Company Conference Presentation
ASX·11/05/2025 03:11
Results of Meeting
ASX·11/04/2025 22:01
AGM Presentation
ASX·10/31/2025 06:23
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·10/14/2025 07:24
Change of Director's Interest Notices
ASX·10/08/2025 00:00
Update - Notification of buy-back - RCE
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others